Status:
UNKNOWN
Virtual Chromoendoscopy With Second Generation NBI (HQ190) vs Chromoendoscopy in Inflammatory Bowel Disease
Lead Sponsor:
Hospital Universitario La Paz
Conditions:
Chromoendoscopy
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Study to compare the detection of neoplastic lesions between chromoendoscopy and NBI
Detailed Description
Single-blind (patient) randomized study to compare detection of neoplastic lesions between chromoendoscopy and NBI. Patients with Inflammatory Bowel Disease who are to undergo chromoendoscopy accordi...
Eligibility Criteria
Inclusion
- Patients with an established diagnosis of Inflammatory Bowel Disease with indication to undergo chromoendoscopy
Exclusion
- Patients who are not trained to understand the nature of the study, the procedures to be followed or are not able to sign an informed consent
- Known allergy or intolerance to methylene blue
- Pregnant or lactating women
- Personal history of colorectal cancer
- Ulcerative colitis active more than 20 cm from the anal verge
- Patients with known G6PD deficiency
- Severe kidney failure
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 25 2022
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT04403997
Start Date
October 1 2019
End Date
February 25 2022
Last Update
July 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario La Paz
Madrid, Spain, 28046